Areas of Focus
- Drug Target Screening
- Early Diagnosis of Invasive Lymphoma
- Chemotherapy Drug Efficacy Prediction
- Gene Function and Application
Publications
- DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines, Hai Jiang, 2022
- Defining relative mutational difficulty to understand cancer formation, Shan, Lin, Yu, Jiao, He, Zhengjin, Chen, Shishuang, Liu, Mingxian, Ding, Hongyu, Xu, Liang, Zhao, Jie, Yang, Ailing, Jiang, Hai, 2020
- SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling, Liang Xu, Peixue Li, Xue Hao, Yi Lu, Mingxian Liu, Wenqian Song, Lin Shan, Jiao Yu, Hongyu Ding, Shishuang Chen, Ailing Yang, Yi Arial Zeng, Lei Zhang, Hai Jiang, 2020
- Systematic Analysis of Drug Vulnerabilities Conferred by Tumor Suppressor Loss, Ding, Hongyu, Zhao, Jie, Zhang, Yanli, Yu, Jiao, Liu, Mingxian, Li, Xiaoxi, Xu, Liang, Lin, Minghui, Liu, Chuan, He, Zhengjin, Chen, Shishuang, Jiang, Hai, 2019
- UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma, Li, Xiaoxi, Zhang, Yanli, Zheng, Liting, Liu, Mingxian, Chen, Charlie Degui, Jiang, Hai, 2018
- A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk, Wang, N, Ding, H, Liu, C, Li, X, Wei, L, Yu, J, Liu, M, Ying, M, Gao, W, Jiang, H, Wang, Y, 2015
- A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency, Liu, Chuan, Ding, Hongyu, Li, Xiaoxi, Pallasch, Christian P, Hong, Liya, Guo, Dianwu, Chen, Yi, Wang, Difei, Wang, Wei, Wang, Yajie, Hemann, Michael T, Jiang, Hai, 2015